| |
News Highlights
June 24, 2008
Concert Pharmaceuticals
Named One of the “Fierce 15" Biotech Companies of 2008
April 30 , 2008
Concert Pharmaceuticals Raises $37 Million in Series C Financing
April 16 , 2008
Concert Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations
March 11, 2008
Concert Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference
January 2, 2008
Concert Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference |
|
Concert Pharmaceuticals uses selective deuterium modification to create important new products by improving validated, marketed and clinically proven drugs. |
|